Insider · CIK 0001712641
Biofrontera AG
Files at BFRI (Biofrontera Inc.). First filing -, latest -.
In brief
Biofrontera AG files SEC Form 4 as director and 10% owner at BFRI (Biofrontera Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Biofrontera AG has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | BFRI Biofrontera Inc. | POpen-market purchase Series D Convertible Preferred Stockderivative | +3,019 | - | - | 3,019 | Sep 18, 2025 |
Questions about Biofrontera AG
Answered from the filings on this page, as of the latest one.
Is Biofrontera AG buying or selling?
Biofrontera AG has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Biofrontera AG's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Biofrontera AG has 0.
Where does Biofrontera AG file Form 4?
Biofrontera AG has filed Form 4 at BFRI (Biofrontera Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.